Cleerly LABS vs eMurmur Heart AI
AI Verdict
Choose Cleerly LABS if…
Choose Cleerly LABS if you require a detailed, AI-powered analysis of coronary CT angiography (CCTA) to precisely quantify atherosclerosis, characterize plaque, and assess stenosis. This tool is ideal for comprehensive risk stratification, guiding personalized treatment strategies, and monitoring the progression of coronary artery disease through advanced anatomical imaging insights.
View Cleerly LABS →Choose eMurmur Heart AI if…
Choose eMurmur Heart AI if you need an efficient, AI-powered solution for automated analysis of heart and lung sounds to detect murmurs and gain hemodynamic insights. This tool is best suited for rapid screening in primary care, telehealth consultations, and continuous monitoring of patients for potential cardiac or pulmonary abnormalities through digital auscultation.
View eMurmur Heart AI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly LABS | eMurmur Heart AI |
|---|---|---|
| Pricing | Varies | Contact for quote |
| Deployment | Cloud, On-premise | Web-based, Mobile App, API integration |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
eMurmur Heart AIeMurmur Heart AI offers broader usability with its mobile app and web portal, coupled with hardware-neutral and stethoscope-agnostic compatibility, making it adaptable to various clinical and telehealth settings. Cleerly LABS, while providing advanced 3D visualization, is primarily a web-based software tailored for specialized CCTA analysis within a radiology or cardiology workflow.
Clinical Value
Cleerly LABSCleerly LABS provides a more advanced and comprehensive assessment of coronary artery disease by quantifying and characterizing plaque from CCTA, which is crucial for personalized risk assessment and potentially preventing heart attacks. While eMurmur Heart AI enhances a fundamental diagnostic skill by automating auscultation, Cleerly's detailed imaging analysis offers deeper, actionable insights into disease progression and management.
Pricing & Value
Cleerly LABSCleerly LABS offers transparent 'per analysis' pricing, allowing healthcare providers to understand the direct cost associated with its use, even if the total cost with the CCTA scan can be significant. In contrast, eMurmur Heart AI's 'contact for pricing' approach lacks transparency, making it difficult to assess its value proposition upfront.
Enterprise Readiness
Cleerly LABSCleerly LABS demonstrates stronger enterprise readiness through its explicit mention of an on-site Cleerly Proxy for robust data transfer and direct integration with PACS, RIS, and EHR systems. This level of integration is critical for seamless adoption within large hospital and imaging center workflows, alongside its cloud-based deployment and compliance.
Innovation
Cleerly LABSCleerly LABS represents a higher degree of innovation by leveraging AI for comprehensive, quantitative characterization of coronary plaque from CCTA, moving beyond simple stenosis detection to personalized risk assessment and disease management. This approach aims to establish a new standard of care for heart disease prevention.
Support & Docs
Cleerly LABSCleerly LABS provides more structured support with specified hours (M-F 10 am-6 pm ET) and a dedicated 'Solution Architect team' for IT integration, which is crucial for complex imaging software in an enterprise environment. While eMurmur offers email support and educational resources, Cleerly's approach appears more comprehensive for its target users.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly LABS | eMurmur Heart AI |
|---|---|---|
| Tool Name | Cleerly LABS | eMurmur Heart AI |
| Company | Cleerly | CSD Labs |
| Description | AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. | FDA-cleared, AI-powered software platform for automated analysis of heart and lung sounds, detecting murmurs and providing hemodynamic insights. It supports digital stethoscopes, mobile apps, and web portals for screening, monitoring, and remote consultation in various healthcare settings. |
| Primary Data Analyzed | Coronary CT angiography (CCTA) | Heart and lung sounds |
| Key Features (Examples) | AI-powered CCTA image analysis, Comprehensive coronary plaque assessment (volume, type), Stenosis detection and quantification | Automated heart and lung sound analysis (S1, S2, murmurs, crackles, wheezes), Detection and classification of pathologic and innocent heart murmurs, Hemodynamic insights (loudness ratios of S1, systole, S2, diastole) |
| Specialties | Cardiology, Radiology | Cardiology, Internal Medicine, Pulmonology |
Videos
Demos, reviews, and walkthroughs featuring Cleerly LABS and eMurmur Heart AI.
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly LABS or eMurmur Heart AI
Backers
Who funded each tool's parent company.